OneMedNet (NASDAQ:ONMD) Director Eric Casaburi Purchases 10,000 Shares

OneMedNet Corporation (NASDAQ:ONMD) Director Eric Casaburi acquired 10,000 shares of OneMedNet stock in a transaction that occurred on Wednesday, October 15th. The stock was purchased at an average price of $3.05 per share, with a total value of $30,500.00. Following the transaction, the director owned 65,475 shares of the company’s stock, valued at $199,698.75. This trade represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

OneMedNet Price Performance

NASDAQ ONMD traded down $0.04 on Thursday, hitting $1.42. 298,140 shares of the company’s stock were exchanged, compared to its average volume of 762,577. The firm has a market cap of $72.43 million, a price-to-earnings ratio of -28.40 and a beta of 1.09. The firm’s 50-day moving average price is $1.77 and its two-hundred day moving average price is $0.99. OneMedNet Corporation has a fifty-two week low of $0.30 and a fifty-two week high of $4.22.

OneMedNet (NASDAQ:ONMD) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.18 million during the quarter.

Institutional Investors Weigh In On OneMedNet

Large investors have recently added to or reduced their stakes in the business. Ashton Thomas Private Wealth LLC acquired a new position in OneMedNet during the third quarter worth about $25,000. Exencial Wealth Advisors LLC grew its position in shares of OneMedNet by 3.1% in the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after purchasing an additional 45,448 shares during the last quarter. Finally, Correct Capital Wealth Management purchased a new position in shares of OneMedNet during the 3rd quarter worth approximately $4,910,000. 0.95% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on ONMD shares. Wall Street Zen upgraded shares of OneMedNet to a “hold” rating in a research report on Friday, September 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, OneMedNet has a consensus rating of “Sell”.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.